Cargando…
Future of antivirals in COVID-19: The case of favipiravir
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666323/ https://www.ncbi.nlm.nih.gov/pubmed/34959188 http://dx.doi.org/10.1016/j.intimp.2021.108455 |
| _version_ | 1784614184033452032 |
|---|---|
| author | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8666323 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86663232021-12-14 Future of antivirals in COVID-19: The case of favipiravir Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Int Immunopharmacol Article Elsevier B.V. 2022-02 2021-12-13 /pmc/articles/PMC8666323/ /pubmed/34959188 http://dx.doi.org/10.1016/j.intimp.2021.108455 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Future of antivirals in COVID-19: The case of favipiravir |
| title | Future of antivirals in COVID-19: The case of favipiravir |
| title_full | Future of antivirals in COVID-19: The case of favipiravir |
| title_fullStr | Future of antivirals in COVID-19: The case of favipiravir |
| title_full_unstemmed | Future of antivirals in COVID-19: The case of favipiravir |
| title_short | Future of antivirals in COVID-19: The case of favipiravir |
| title_sort | future of antivirals in covid-19: the case of favipiravir |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666323/ https://www.ncbi.nlm.nih.gov/pubmed/34959188 http://dx.doi.org/10.1016/j.intimp.2021.108455 |
| work_keys_str_mv | AT kowchiasiang futureofantiviralsincovid19thecaseoffavipiravir AT ramachandramdineshsangarran futureofantiviralsincovid19thecaseoffavipiravir AT hasansyedshahzad futureofantiviralsincovid19thecaseoffavipiravir |